Featured Insights
-
Discover The Path To Oncology Success
8/22/2025
The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.
-
Navigating Global Health Policy In A Time Of Disruption
8/12/2025
The healthcare industries in the U.S. and EU are undergoing significant regulatory and legislative changes. Learn how to better position yourself to navigate this complex environment.
-
Patient Empowerment Through The European Health Data Space (EHDS)
8/12/2025
A new regulation in the EU will give patients more control over their health data. Discover the opportunities and challenges this shift presents for the future of patient-centric healthcare.
-
Unlocking Innovation: New Models And Next-Gen Tech For Success
8/12/2025
AI and digital innovation are reshaping the pharmaceutical landscape. Learn how the industry is leveraging data and technology to enhance commercialization and improve patient outcomes.
-
Enhancing The Biosimilar Review Process
8/12/2025
The biosimilar market is projected to reach over $100 billion in the next five years. Learn how to navigate the expanding landscape and overcome challenges in accessing key clinical information.
-
How PIE Streamlines Biopharma And Payer Communication
8/12/2025
Navigating pre-approval information exchange (PIE) with healthcare decision-makers is essential for market success. Learn what information can be shared and the best strategies for communication.
-
Advancing Drug Safety: The Synergy Of Regulatory Affairs And Pharmacovigilance
7/14/2025
Explore how pharmacovigilance and regulatory affairs teams work together throughout a product's lifecycle to monitor risks and keep vital safety information updated.
-
CDISC + TMF Europe Interchange 2025: 5 Key Takeaways
7/14/2025
The CDISC + TMF Europe Interchange showcased critical insights for TMF professionals. Learn about essential collaboration, the impact of AI, and the continued drive for standardization in clinical trials.
-
How Digital Twins And Hybrid Modelling Optimize Cell Culture Process For Better Production
7/14/2025
Discover how digital twins are enabling the optimization of cell culture processes for improved, more predictable outcomes in the creation of therapeutic proteins and antibodies.
-
The New Language Of E6 R3: What Makes The Guidelines So Different?
7/14/2025
Unpack the significant changes in ICH E6 (R3), nearly a decade after its last update. This revision brings renewed focus to quality by design and digital provenance.